About this trial
This study aims to assess whether transmusculr quadratus lomborum block (QL block) can reduce postoperative pain after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (CRS and HIPEC). Patients will be randomly assigned to either QL block group or control group. Ultrasound-guided bilateral transmuscular quadratus lomborum block will be performed in QL block group using 0.375% ropivacaine. Multimodal analgesic regimen including acetaminophen, nonsteroidal antiinflammatory drugs (NSAIDs), and rescue opioids will be used in every patient. Primary outcome is opioid consumption for 24 hours after surgery. Secondary outcomes included pain scores, time to first rescue analgesics, quality of recovery score, length of hospital stay.
Eligibility criteria
Qualifiers
None
Disqualifiers
Allergy to local anesthetics or fentanyl
Chronic pain
Drug abuse
Patients who are unable to use patient-controlled analgesia
Trial design
Treatments tested in this trial
- Arm I (QL block and multimodal analgesia), Arm II (multimodal analgesia without regional block)